Unum Group's fair value estimate has been increased to approximately $100.08, aligning with a refreshed $100 price target, following a $3.8 billion long term care reserve cession to Fortitude Re. The deal prompted several analysts to raise their price targets, with Jefferies lifting its target to $123 from $117, Barclays to $110 from $105, and Evercore ISI to $106 from $103, while Wolfe Research adjusted its target to $100 from $102 and maintained an Outperform rating, arguing the transaction reinforces the view that Unum's long term care block is transactable and could make the company a stronger takeout candidate. The fair value revision also reflects a slightly improved long term revenue growth outlook, now projecting an annual decline of about 11.0% versus 11.08% previously, and a modest uptick in forecast net profit margin to around 11.16% from 11.11%, with the future P/E multiple moving to about 10.85x from 10.64x. Some caution persists, as Wolfe Research noted Unum shares underperformed on the announcement date, suggesting some investors may be assigning less value to future reserve deal catalysts.
Unum GroupUnum's fair value estimate raised to $100.08 and multiple analysts raised price targets after a $3.8 billion long term care reserve cession deal, improving financial outlook.
Barclays PLC
Evercore Partners Inc
Jefferies Financial Group Inc